hc1 announced the launch of HerCare, an industry-first module within its MyBloodHealth platform designed to safeguard maternal health by identifying and addressing health risks associated with anemia in pregnancy.
Through hc1’s HerCare, obstetrics teams can analyze lab biomarkers and clinical data in real time to provide clinicians with actionable insights that prevent serious anemia issues before they become critical.
hc1 is rolling out HerCare to current MyBloodHealth customers on a limited basis. The company will offer HerCare more widely to hospital systems and obstetrics practices in late 2025.
HerCare aims to reduce preventable complications by:
- Early risk detection: Identifying patients at risk through real-time monitoring of lab results and clinical data.
- Personalized care: Offering tailored insights to guide decisions that enhance patient safety.
- Clinical decision support: Assisting healthcare providers with data-driven recommendations for timely interventions.
For more information about HerCare and MyBloodHealth, visit www.hc1.com.
